CAM, SAM, K Law act on ChrysCapital, Tata Healthcare Fund III acquiring stakes in Linux Laboratories

Tata Capital Healthcare Fund II exited from Linux Laboratories in this transaction.
Linux Laboratories
Linux Laboratories
Published on: 
2 min read
Listen to this article

ChrysCapital Group and Tata Capital Healthcare Fund III have acquired stakes in Linux Laboratories Private Limited by way of secondary acquisition of shares from the Promoters and exiting investor Tata Capital Healthcare Fund II and, a primary subscription to shares proposed to be issued by the Target Company.

Tata Capital Healthcare Fund II exited from Linux Laboratories, while Tata Capital Healthcare Fund III came in as a new investor.

Cyril Amarchand Mangaldas advised Linux Laboratories on this transaction.

The transaction was led by Ravi Shah (Partner), with support from Vidhi Shah (Senior Associate Designate), Neeti Amin (Senior Associate) and Aeruva Akash (Associate).

Biplab Lenin (Partner), with support from Anam Chowdhary (Associate) assisted with certain regulatory aspects of the transaction.

Ravi Shah, Biplab Lenin
Ravi Shah, Biplab Lenin

Shardul Amarchand Mangaldas & Co advised ChrysCapital Group on all legal aspects of the investment.

The transaction was led by Karun Prakash (Partner) and Sangamitra Sankaraiah (Partner), with support from Simran Khullar (Senior Associate), Amrusha Monga (Senior Associate) and Aradhana Parmeshwar (Associate).

The due diligence team included Karun Prakash, Sangamitra Sankaraiah, Pooja Ramchandani (Partner), Devaditya Chakravarti (Counsel), Suryansh Gupta (Principal Associate), Simran Khullar (Senior Associate), Associates Aradhana Parmeshwar, Shivani Pattnaik, Aagam Jain, Faiz Ahmad and Shalini Prem.

Rohan Arora (Partner) and Rahul Shukla (Principal Associate) advised on competition law aspects.

Karun Prakash, Sangamitra Sankaraiah, Pooja Ramchandani, Rohan Arora
Karun Prakash, Sangamitra Sankaraiah, Pooja Ramchandani, Rohan Arora

Krishnamurthy & Co (K Law) advised Tata Capital Healthcare Fund II (TCHF II) on its exit from Linux Laboratories, and Tata Capital Healthcare Fund III (TCHF III) on its investment in the company.

Rukmini Roychowdhury (Co-Managing Partner), along with Rhea Sethi (Principal Associate) and Abhimanyu Rajguru (Senior Associate) advised TCHF II on its exit.

Roychowdhury, along with Sethi and Divya Lala (Associate) also advised TCHF III on its investment in Linux Laboratories.

Rukmini Roychowdhury
Rukmini Roychowdhury

Linux Laboratories is a pharmaceutical company with a presence across neuro-psychiatry, dermatology, nutraceuticals and cardio-diabetics.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Bar and Bench - Indian Legal news
www.barandbench.com